UCHealth has updated the UCHealth Guidelines for Research Involving Human Subjects During COVID-19 Outbreak reactivation revisions, effective 18 SEPT 2020.

Notably, UCHealth has revised its visitor restrictions  and we have updated our sponsor SIV/site visit guidelines:

For projects requesting an SIV or site visit, study teams can request permission from the UCHealth clinical or ancillary department where their research is performed. UCHealth departmental leadership will determine if they are allowing visitors in their area and if they can accommodate this request. Currently, the ACP (oncology) IDS Pharmacy at UCHA cannot accommodate any outside visitors as they are in a temporary space due to construction.

If you have any questions, please contact Laurie Blumberg-Romero directly or email the UCHealth research administration central box at: UCH-ResearchAdmin@uchealth.org

UCHealth has updated the UCHealth Guidelines for Research Involving Human Subjects During COVID-19 Outbreak reactivation revisions, effective 18 SEPT 2020.

Notably, UCHealth has revised its visitor restrictions  and we have updated our sponsor SIV/site visit guidelines:

For projects requesting an SIV or site visit, study teams can request permission from the UCHealth clinical or ancillary department where their research is performed. UCHealth departmental leadership will determine if they are allowing visitors in their area and if they can accommodate this request. Currently, the ACP (oncology) IDS Pharmacy at UCHA cannot accommodate any outside visitors as they are in a temporary space due to construction.

If you have any questions, please contact Laurie Blumberg-Romero directly or email the UCHealth research administration central box at: UCH-ResearchAdmin@uchealth.org